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It is unclear how consumer participation (CP) can be optimised to transform drug and 
alcohol treatment services and improve health outcomes. This paper presents the 
findings of a systematic review examining the types and benefits of activities, and the 
factors that facilitate CP in drug treatment services.  
Design 
A structured search of four databases was undertaken to identify peer reviewed 
primary research literature in English. Screened articles were appraised. A content 
analysis was applied to examine the types and outcomes of CP and the associated 
factors affecting the process. Sixteen articles were included for review. 
Findings 
A range of CP activities were identified, and benefits included increased consumer 
satisfaction, and improved health service delivery. Factors that facilitated the process 
of CP included positive attitudes of both consumers and providers and employment 
of people with a lived experience of drug use. However, the lack of consumer and 
organisational capacity, negative attitudes of providers and power imbalances 
between consumers and providers constrained CP efforts. 
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Practical implications  
To maximise the benefits of CP in drug and alcohol treatment services, negative 
attitudes about CP and power dynamics between consumers and health providers 
need to be addressed. This can be achieved by - through the strategic use of 
strengths-based interventions and consumer led education to enhance social capital.  
Originality/value 
This is the first known review to examine the benefits and facilitators of consumer 





Consumer participation (CP) in health care transpires when consumers are 
‘meaningfully involved in decision-making about health policy and planning, care and 
treatment, and the wellbeing of themselves and their community’ (ACT Government 
Health, 2011: p. 7). CP arose from social change movements in the 1960’s and 
1970’s that included Black Power in the United States and women’s and gay 
liberation (Tomes, 2006). In 1978 the World Health Organisation initiated CP in 
health care (Shea et al., 2005). This action is supported by the Declaration of Alma 
Ata that promotes equity and social justice in health care by ensuring people have 
‘the right and duty to participate individually and collectively in the planning and 
implementation of their health care’ (WHO, 1978: p.1). There is reliable evidence that 
involving consumers in the delivery of health care leads to more satisfactory, safer, 
higher quality care and improved health outcomes (Institute of Medicine, 2001). As a 
result, CP has become a high priority for many governments and policy makers 
(Tambuyzer et al., 2014) and is necessary to achieve the co-production of health 
care services (Batalden et al., 2016). 
 
Several governments around the world have introduced policies and guidelines to 
guide consumer involvement in drug treatment services. The government of the 
United Kingdom was the first to legislate CP in drug treatment services and as a 
result is considered a world leader (Hinton, 2010). The UK collects data about CP in 
mutual aid engagement activities, such as peer run groups and smart recovery, 
which is based on the principles of cognitive behavioural therapy. (NDTMS, 2016). 
Examples of successful drug treatment involving CP are provided in the national 
guidelines (Public Health England, 2015). Despite these efforts, CP in drug treatment 
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services in the UK are ‘patchy and sometimes tokenistic’ (Hinton, 2010 p. 25). This is 
because CP is often poorly resourced and not embedded into strategic objectives of 
the service (Hinton, 2010). As a result, services are streamlined and cannot be 
tailored to meet individual’s needs.  
 Furthermore, some consumers are excluded from contributing to service delivery 
because they are incarcerated or live in rural areas with poor transport and services 
that are geographically dispersed (Hinton, 2010). 
 
CP has been implemented for several decades in mental health services. One 
review in this care context showed that employing consumers within these services 
leads to greater consumer satisfaction and reduced hospital admissions (Simpson 
and House, 2002). Consumer-led services have also resulted in positive employment 
and accommodation outcomes for mental health consumers (Doughty and Tse, 
2011).  
  
Four reviews have explored CP in drug treatment services. The first focused on 
consumers’ perspectives regarding provider training to ensure they are responsive to 
consumers’ needs (Wylie, 2010). The second reviewed studies that focused on the 
involvement of people who use drugs in policy and program development noting the 
lack of evidence regarding their participation on policy committees (Ti et al., 2012). 
The third critically reviewed studies that reported results of consumer satisfaction 
surveys in drug treatment services (Trujols et al., 2014). The fourth investigated how 
consumers’ perspectives are incorporated into surveys designed to inform service 




While these reviews are informative, gaps remain in fully understanding the factors 
that enable or inhibit consumers’ involvement in drug treatment services. An 
awareness of these factors is critical to realising the benefits of consumer 
involvement in these services.  
 
Levels of CP 
Bryant et al. (Bryant et al., 2008a, Bryant et al., 2008b) have conceptualised the 
participation of consumers in drug treatment services in a hierarchical manner, 
illustrated as a ladder that depicts various levels of involvement (Table 1). At the 
lower rungs of the ladder consumer participation is classified as activities such as the 
use of surveys to gain insight into consumer satisfaction with services (Bryant et al., 
2008a, King, 2011, Patterson et al., 2009a, Patterson et al., 2009b, Schulte et al., 
2007). At the upper end of the ladder are more complex activities, such as the 
involvement of consumers in decisions about service planning and delivery and the 
selection of new employees.  
 
Table 1. here 
There is a need to understand the factors that impact upon CP policy, the ability of 
organizations and individuals to successfully engage consumers in all aspects of 
service delivery and the socio-economic outcomes that arise from positive CP. The 
aim of this systematic review therefore is to identify the types of activities that are 
associated with CP, their associated outcomes and the factors that facilitate or 






A search of the electronic databases Medline Ovid, Embase Ovid, and Scopus and 
Drug Database was performed in January 2018 to retrieve peer reviewed research 
publications in English. One additional article was sourced from a reference list. 
While no date limit was applied, no literature regarding CP and drug treatment was 
retrieved prior to 2007. The search was conducted using the following key terms: 
‘consumer participation’, or ‘patient participation’ or ‘client participation’ or ‘user 
involvement’ or ‘peer’ or ‘empowerment’ and ‘drug treatment’ or ‘drug treatment 
services’ or ‘harm reduction services’ or ‘drug and alcohol services’ or ‘substance 
abuse treatment centers/centres’. Table 2 outlines the inclusion and exclusion 
criteria that were applied. 
Table 2 here 
The initial search located 1004 items that was reduced to 1516 after removing 
duplicates and those that did not meet the inclusion criteria (see Figure 1)  
Appraisal of Studies 
The criteria Critical Appraisal Skills Programme (CASP, 2014) were used to appraise 
the quality of the nine qualitative studies; two were excluded as they did not fully 
outline the methodology. The CASP Case Control Study Checklist, CASP Cohort 
Study Checklist and the Joanna Briggs Checklist for Analytical Cross-Sectional 
Studies (Joanna Briggs Institute, 2017) were applied to the seven quantitative 
studies; none were excluded. 




Data extraction and synthesis 
Full text data were extracted from the 16 papers and first described according to 
general study characteristics. A directed content analysis was then employed, as 
outlined by Dawson et al.(2015), to organise the data on a table based on the CP 
ladder, thus enabling comparison of the findings across key areas. Activities were 
identified as lower, mid and higher on the ladder alongside the reported associated 
benefits and the factors that facilitated or constrained them. Table 3 outlines the 
characteristics and findings of the 16 studies. 
 
Table 3 here 
 
Results 
Of the sixteen studies were included in the review fourfive employed quantitative 
research methodologies, tennine used qualitative approaches and two applied mix 
methods methodologies. Seven of the studies originated in Australia, seven in the 
United Kingdom, one in Finland and one in Canada. The study sites included 
government and non-government detoxification services, residential rehabilitation 
units, opioid substitution clinics, drug and alcohol policy committees, harm reduction 
service and drug and alcohol counselling services.  
 
Consumers were involved in a variety of lower to mid activities that included 
completing satisfaction surveys, facilitating groups, operating a café and a drop-in 
centre and educating providers. A range of higher level activities were described, 
such as: involvement in the development of a consumer charter of rights, consumers 




staff recruitment, quality assurance activities, research commissioning and 
coproducing services.  
Benefits of CP:  
Improved service delivery 
In five studies (Bryant et al., 2008b, Greer et al., 2016, Patterson et al., 2009b, Tober 
et al., 2013) service quality was enhanced when the views of service users were 
incorporated through consumer representation on decision making committees, open 
councils or forums and service expansion projects. These improvements included: 
enhanced consumer–centred care (King, 2011), decreased waiting times and 
revised operating hours (Bryant et al., 2008b, Patterson et al., 2009b), increased 
consumer survey response rate about service reconfiguration (Patterson et al., 
2009b) and better opportunities for social support, self-help, and networking 
(Patterson et al., 2010). Consumer groups were found to support consumers through 
the stages of addiction and recovery by assisting them to better access treatment 
services, providing additional information about services, offering advocacy in the 
case of problems with a provider, and providing alternative forms of support for 
consumers who did not wish to engage in prescriptive programmes such as 
Narcotics/ Alcoholics Anonymous (Van Hout and McElrath, 2012). 
 
Consumer input was found to expand the current range of available services such as 
the development of an aftercare service (Tober et al., 2013), an inpatient unit, a day 
program, and mobile treatment service and the introduction of buprenorphine to 
increase treatment options (Patterson et al., 2009b). Consumer input also led to the 
development of improved harm reduction interventions, such as a take home 
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naloxone program and the provision of a wider range of safer inhalation supplies 
(Greer et al., 2016) and injecting equipment (Patterson et al., 2009b). 
 
Increased satisfaction and goal achievement 
Studies revealed that consumers who participated in planning and delivering 
services including the type of drug treatment they wished to undertake, enjoyed high 
levels of satisfaction (Brener et al., 2009, Patterson et al., 2009b) and goal 
achievement (Brener et al., 2009). A survey of 492 consumers found that consumer 
satisfaction increased when consumers participated in planning their treatment and 
that this participation increased awareness of their rights (Brener et al., 2009). 
Brener et al. (2009) also reported that the achievement of treatment goals was 
associated with being involved in a review of the service and having knowledge of 
grievance procedures.  
 
Empowerment 
Involving consumers in CP activities was found to foster consumer empowerment as 
their participation altered the power dynamics of the consumer-provider relationship 
(King, 2011, Patterson et al., 2009a, Rance and Treloar, 2015) and reduced the 
stigmatisation of service users (Patterson et al., 2009a). CP decreased the 
interpersonal distance between consumers and providers (Patterson et al., 2009a), 
allowing them to see each other’s human qualities (Rance and Treloar, 2015) and 
finding common ground (Tober et al., 2013). As a result, consumers were able to 
gain confidence and a sense of ownership over aspects of the service (Patterson et 




Consumer empowerment was affected by the ethos underpinning the health service 
itself. Providers who worked in harm reduction services were found to be less 
paternalistic than those who worked in more traditional setting such as a drug 
treatment service for pregnant woman (Leppo and Perala, 2009). 
  
Health care organizations that facilitated consumer led training were found to have 
empowered consumers, improved relations between consumers and providers and 
decreased stigma and staff discrimination towards consumers (Roussy et al., 2015). 
As a result, providers stated that they gained a greater understanding of needs of 
people with both substance use and mental health disorders and felt more 
competent in their caring role. Consumers also became empowered as members of 
harm reduction committees, as their membership helped them to become involved in 
their community, develop confidence and skills, and become inspired by peer 
leaders (Greer et al., 2016). 
 
Consumers reported that they became more confident to express their needs 
through their involvement in participatory activities. One consumer expressed this by 
stating that, ‘I think it is important that users have a voice ‘cause we are people too’ 
(Rance and Treloar, 2015 p. 33). Consumers also reported this ‘voice’ could be 
political in nature (Rance and Treloar, 2015), thus invigorating their desire for social 
justice (Patterson et al., 2009a). Therefore, a voice helped consumers educate the 
public and raise awareness about issues that impact them (Rance and Treloar, 
2015, Patterson et al., 2010), such as the need for the decriminalisation of drug use, 
reforms in prescribing policies, and making drug treatment more accessible and 
respectful (Patterson et al., 2009a). The consumers’ voice also informed the 
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development of participatory activities that helped to create solidarity among 
consumers and enabled collective feedback to be presented to service providers 
(Patterson et al., 2010). 
 
Facilitators of CP:  
Supportive attitudes of consumers and providers 
Eight studies revealed that the supportive attitudes of consumers and professionals 
encouraged consumers to be more involved in drug treatment service delivery and 
planning (Greer et al., 2016, King, 2011, Patterson et al., 2009a, Patterson et al., 
2009b, Patterson et al., 2010, Rance and Treloar, 2015, Tober et al., 2013, Van Hout 
and McElrath, 2012). Attitudes reflecting values that CP was fundamental to effective 
service delivery facilitated consumer–centred care through developing an 
understanding of service users’ individual and collective needs (King, 2011, 
Patterson et al., 2009a). Therefore, CP was facilitated by an organisational culture 
that embodied optimistic views and an appreciation of consumer contributions (Van 
Hout and McElrath, 2012), and mutual respect (Patterson et al., 2009b) that allowed 
consumers and staff to work towards a collaborative ethos (Rance and Treloar, 
2015). 
 
Such organisations demonstrated these values through adequate funding and 
dedicated time to participatory initiatives (Greer et al. 2016, Patterson et al., 2009b). 
Other aspects of these organisations included well-defined internal and external 
communication pathways (Patterson et al., 2010), clearly articulated expectations 
(Greer et al., 2016), and the provision of feedback on the progress and outcome of 




Employment of consumers with lived experience 
Three quarters of consumers in the Schulte et al. (2007) study were supportive of 
people with a lived experience of drug use being employed on a voluntary or paid 
basis. Consumer employment was underpinned by the understanding that they are 
well-informed, have the knowledge, understanding and credibility to be effective 
(Treloar et al., 2011) and are more empathic, as they have similar life experiences as 
consumers (King, 2011). The mentors who helped produce an aftercare service 
reported that their lived experience of recovery helped other consumers to see that it 
is ‘possible to move on [and] to learn to live again’ (Tober et al., 2013 p. 231). 
 
Patterson et al. (2009b) reported that people with a lived experience working in drug 
treatment facilities required specific training that included information about the 
service structure and processes and formal meeting procedures such as agendas, 
chairing meetings and minute taking. It was also suggested that this training should 
be self-reflective, so consumers can review their learning and performance. Training 
ultimately helped consumer representatives progress to paid positions within drug 
services. (Patterson et al., 2009b). 
 
Constraints of CP 
Perceptions of consumers’ capacity  
Service providers were reluctant to involve consumers, especially in higher level 
activities such as staff training, recruitment and performance appraisal, because they 
thought that consumers did not possess the skills or interest to successfully 
undertake such activities (Bryant et al., 2008b, Patterson et al., 2009b, Schulte et al., 
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2007, Van Hout and McElrath, 2012). Providers in Patterson et al. (2009a) study 
‘questioned the legitimacy of involving people who ‘choose’ to use illicit substances 
and therefore have ‘self-inflicted problems’ ‘[p.57]. Even when active CP was 
embedded into services, providers expressed doubt about the sustainability of these 
activities as consumers were viewed as unstable, manipulative, untrustworthy, 
powerless, vulnerable and lacking in capacity to participate because of their chaotic 
lifestyles and social problems (Patterson et al., 2009a, Patterson et al., 2010, Treloar 
et al., 2011, Van Hout and McElrath, 2012). Fears that consumers may relapse or 
would endanger the recovery of those who were abstinent were also expressed (Van 
Hout and McElrath, 2012, Tober et al., 2013).  Providers were also reluctant to 
involve consumers in service delivery because they lacked trust in them and were 
concerned about their strong opinions (Patterson et al., 2009b) and disparate 
(Patterson et al., 2010) and unrealistic (King, 2011) expectations about service 
delivery. 
 
Consumers also expressed the view that it was not their place to be involved in staff 
matters because they perceived that they did not have: the necessary skills (Bryant 
et al., 2008b, Patterson et al., 2009a), stability (King, 2011, Treloar et al., 2011), 
interest, confidence or entitlement to participate (King, 2011). Mentors who co-
produced an aftercare service reported they felt uncomfortable and confused about 
their boundaries when consumers disclosed information that they usually relayed to 
a therapist because they lacked counselling skills (Tober et al., 2013). In another 
study providers were worried that peer workers would disregard guidelines, 
interpersonal boundaries and confidentiality issues, because they lacked formal 




It was also revealed consumers were unaware of opportunities to participate due to a 
lack of knowledge about CP in principle or in practice (Patterson et al., 2009a). 
Several studies reported that consumers did not know how to make a service 
complaint (Bryant et al., 2008a, Brener et al., 2009), nor did they know the location of 
the suggestion box (Bryant et al., 2008a). In another study consumers and providers 
were unaware of the service user support team whose role was to advocate on 
behalf of consumers (Van Hout and McElrath, 2012). 
 
Studies have also questioned consumer groups’ capacity to represent the diverse 
range of people that engage with drug treatment services (Patterson et al., 2009b, 
Patterson et al., 2010, Van Hout and McElrath, 2012). It was reported that cliques 
often occur in drug user groups (Patterson et al., 2009a), and they are perceived as 
‘exclusive’ (Patterson et al., 2010). Consequently, this limits group membership, as 
selection of members is frequently based on therapeutic orientation, drug user status 
or relationship with the group convenor (Patterson et al., 2010). It was suggested 
that service user forums need to increase their visibility to broaden their membership 
and include prisoners, gay, lesbian and transgender people, and migrants to ensure 
a more accurate representation of drug treatment consumers (Van Hout and 
McElrath, 2012). 
 
Power imbalances between consumers and providers  
Providers reported that they were reluctant to involve consumers in service planning 
and delivery because of the hierarchical professional-client relationship, described as 
the ‘them and us’ divide that emphasized beliefs that healthcare providers know best 
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(Leppo and Perala, 2009, Patterson et al., 2009b, Rance and Treloar, 2015). 
Providers were found to be resistant and concerned about moves towards 
establishing more equal power relationships (Rance and Treloar, 2015, Treloar et al., 
2011), as they feared that professional authority might be undermined. Such views 
were said to perpetuate negative and judgemental views towards consumers (King, 
2011, Patterson et al., 2010, Patterson et al., 2009a, Patterson et al., 2009b, Van 
Hout and McElrath, 2012).  
 
Consumer representation on committees (Greer et al., 2016, Lancaster et al., 2017) 
was found to be ‘weighted towards scientific voices’ (Lancaster et al., 2017: p. 64) 
that maintained professional dominance in decision making. In addition, consumer 
knowledge was often seen as illegitimate, as it represented ‘the antithesis of clear 
and systematic reasoning’ (Lancaster et al., 2017: p. 65).  
 
Power divides and conflicts between consumers and staff were reported to be 
intensified by abstinence-related punitive rules set by residential treatment services 
(King, 2011). Consumers were reluctant to make complaints against staff because 
they worried that staff would assert their power by restricting medication or excluding 
them from services (Patterson et al., 2009a).  
 
Low organisational capacity 
A lack of organisational direction from government and support for consumer 
positions that enable consumer advocacy was found to negatively affect the ability of 
managers to bring about change (Van Hout and McElrath, 2012). The low value of 
consumer support positions was also explained by inadequate terms of reference 
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(Van Hout and McElrath, 2012), poor organisational drive and obstruction to 
programs (King, 2011), and insufficient commitment from government (King, 2011, 
Patterson et al., 2009a). Other studies reported that poor allocation of financial and 
human resources constrained CP projects (King, 2011, Patterson et al., 2009a, 
Patterson et al., 2009b, Patterson et al., 2010, Schulte et al., 2007, Treloar et al., 
2011, Van Hout and McElrath, 2012). These studies found that CP was not 
considered ‘core business’ and that projects were often disrupted because of staff 
resignations, poor staff hand over (Greer et al., 2016, Treloar et al., 2011) and 
organisational time constraints (Patterson et al., 2009b).  
 
Patterson et al. (2009a) reported that the focus on attaining performance targets, 
undermined the resources, energy, and commitment required for CP. Staff also often 
under estimated the amount of work required to undertake a CP project and did not 
value training in this area (Treloar et al., 2011).  
Discussion 
This review has revealed that CP has the potential to enhance drug treatment 
services and health outcomes. CP can increase consumer access to improved and 
expanded services, improve consumer satisfaction, relationships between staff, and 
consumers, reduce individual providers’ negative attitudes and help consumers 
achieve their treatment goals. CP activities ultimately empower consumers by giving 
them a voice and the skills knowledge and confidence they require to actively and 
meaningfully contribute. However, CP is predicated upon a service delivery context 
that values consumer contributions through clear commitment that is articulated in 




Even though CP policy has been enshrined into policy, attitudinal change at an 
organisational level which facilitates the translation of policy into practice at service 
level remains a challenge. Despite the existence of CP policies at the macro level, 
consumer involvement in drug treatment services is constrained by organisational 
cultures at the micro level. Consequently, CP initiatives are often poorly conceived 
and inadequately resourced, especially higher-level activities. Attempts to 
incorporate higher levels activities into drug treatment service delivery are often not 
sustained due to organisational instability, including frequent staff changes, 
insufficient handover of CP projects and the low value of CP as core business 
(Treloar et al., 2011). 
 
If CP is to succeed in drug treatment services, the notion that consumers are 
incapable of contributing also needs to be challenged. Some providers will be 
reluctant to meet these challenges, as drug and alcohol services ‘are framed by an 
environment that is strongly risk averse’ (The Royal Australian and New Zealand 
College of Psychiarists, 2012: p. 18). This is reflected in the physical environment of 
treatment services that are often fitted out with bullet-proof glass and buzzing doors, 
which reinforces the notion that consumers are associated with danger and crime 
(Crawford, 2013). As a result, providers are often reluctant to involve consumers in 
service delivery because they are perceived as ‘criminals’, ‘addicts’ and ‘junkies’ 
(Radcliffe and Stevens, 2008, Crawford, 2013, Harris and McElrath, 2012). Such 
conceptions of substance dependence necessitate change in order to improve 




Since the 1970’s substance dependence has been viewed through a pathological 
lens (Siegal et al., 1995) and over the past twenty years in the American Diagnostic 
and Statistical Manual of Mental Disorders substance dependence has been 
increasingly conceptualised biological in nature (Nathan et al., 2016). Furthermore, 
drug rehabilitation treatment is dominated by programs that claim that individuals 
with substance dependence are ‘diseased’ and ‘powerless’ (Anonymous, 2014). 
Describing individuals with substance dependence in this manner reinforces criminal 
stereotypes such as the ‘junkie’ (Crawford, 2013). In addition, stigma and 
discrimination restrict involvement of consumers in policy and program development 
(Ti et al., 2012). Overall, a purely biological/diseased and stigmatised view of 
substance dependence reinforces the belief that drug treatment consumers lack 
capacity not only to contribute to their own care but also service delivery and 
planning. 
 
To overcome the notion that drug treatment consumers lack capacity, a strength-
based model is required to move beyond a focus on an individual’s pathology or 
deficits (Rapp and Goscha, 2011) to a systematic assessment of a consumers’ skills, 
attributes and assets (National Registry of Evidence-Based Programs and Practices, 
2009). This model is based on the creation of egalitarian consumer-professional 
relationships with consumers’ directing the helping process (Rapp and Goscha, 
2011). These strategies flatten the hierarchical expert-patient relationship that 
dominates drug treatment services and constrains consumer participation (Putman, 
1993). More harmonious and equal relationships help to foster an environment 
where the consumers’ voice is more likely to be considered. A way to promote such 




Social capital as conceptualised by Putnam are the ‘features of social organizations, 
such as networks, norms, and trust that facilitate action and co-operation for mutual 
benefit’ (Putman, 1993: p. 35). Shared connections between consumers can be 
developed through activities such as the service user support teams, as described 
by Van Hout and McElrath (2012). Here social capital can be built through the 
bonding of consumers. Bridging social capital or enhancing the connections between 
different consumers and staff in treatment services can be achieved by consumer 
training of staff that promotes an understanding of consumer needs and awareness 
of the importance of mutual respect (Roussy et al., 2015), and well-defined 
communication channels (Patterson et al., 2010). Engaging diverse groups of 
consumers in decision making committees within treatment services is key to linking 
social capital by increasing the degree to which people create relationships with 
institutions and individuals who have considerable amount of power over them 
(Woolcock, 2001). Building social capital will therefore help to reduce the power 
differentials that constrain CP. 
 
Harnessing the opportunities for social capital can help drug treatment organisations 
improve performance as teamwork is an essential element of quality healthcare 
(Norrish et al., 2013). High levels of social capital are associated with improved drug 
treatment and harm reduction outcomes such as reduced risk of relapse 
(Panebianco et al., 2016) and overdose (Zoorob and Salemi, 2017), recovery from 
substance and alcohol dependence (Granfield and Cloud, 2001, Weston et al., 




In mental health care the recovery movement has been particularly successful 
supporting people who experience mental illness to gain increased levels of social 
capital. This has been achieved as a result of the consumer driven nature of the 
recovery movement that focuses on self-determination through the provision of 
opportunities for people with mental illness to contribute to mainstream society 
through work and education (Davidson, 2016). This has enabled mental health 
consumers to gain a voice and a renewed sense of hope (Meehan et al., 2008). In 
the UK, drug treatment services are starting to follow by providing opportunities such 
as sustained employment as part of treatment (Black, 2016). 
  
While activities to build social capital to address the treatment needs of consumers 
and better engage consumers in their own care are required, these will need to be 
tailored to fit individual contexts. The ladder of consumer participation depicts a 
range of activities that can be implemented to change power dynamics and empower 
consumers. However, it must be noted that different types of knowledge and 
expertise are central to the process of citizen participation require a comprehensive 
approach to capacity building. In addition, not all people will desire power or want to 
be involved in decision-making activities (Tritter and McCallum, 2006). 
 
Even though it is useful to depict the power dynamics at the various levels of the 
ladder the activities and processes in drug treatment service delivery are not 
straightforward or linear. This is because the different levels of activity take place 
simultaneously and there is a variation in the degree to which consumers are willing 
to participant and the activities in which they are willing to engage. For example, 
some consumers will not want to participate, as they may wish to concentrate on 
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their treatment, some will be pleased to contribute by completing a satisfaction 
survey, while others will be highly motivated to volunteer their time, for example, by 
being a consumer representative on a committee that informs policy. 
 
A framework for consumer participation would be improved by visualising 
participatory activities in a more dynamic fashion, with participatory activities 
displayed in an integrated manner rather than ranked within a hierarchy. This will 
allow for reference to “bundles” of activities from all levels of the ladder to better 
illustrate the complexity and need for tailoring according to the context. The ladder 
also does not consider the full spectrum of consumer participation. For example, the 
ladder does not describe consumers who choose not to participate, and consumers 
who are employed in drug treatment services because of their lived experience of 
drug use and recovery.  
  
Limitations  
A limitation of this review is that only literature published in the English language has 
been included. In addition, there was no literature related to closed settings such as 
prisons and involuntary treatment, where unequal power dynamics are exacerbated. 
Therefore, the synthesis may have led to a loss of detail, particularly of contextual 
factors that are important to the outcomes of the various CP interventions. 
Implication for research 
Future research needs to focus on how current policy decisions impact upon 
providers attitudes towards CP and on the commissioning and monitoring of 
services. Therefore, it would be useful to investigate staff experience, professional 
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development and communication skills and how these factors impact on their 
attitudes and the implementation of CP projects.  In addition, the barriers to CP for 
prisoners, migrants, gay, lesbian and transgender people needs to be investigated 
as well as for those consumers who are not candidates for 12-step philosophy of 
treatment. 
Conclusion 
If drug treatment services do not invest in social capital positive attitudes towards CP 
drug treatment services may not evolve to successfully address consumer needs. 
Consumers’ capacity to contribute requires a supportive organizational environment 
to challenge notions of ‘staff know best’ so that quality care and services can be 
optimised. In addition, the current ladder of CP in drug treatment needs to be 
transformed so all forms of participation are equally valued and increased ‘buy in’ 
from strategic bodies and commissioning teams is required. 
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